The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation obesity medicines.

Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

Genentech, a Bay Area-based biotech firm and member of the Switzerland-based Roche Group, plans to develop a $700 million pharmaceutical manufacturing facility in Holly Springs, approximately 20 miles ...

Swiss pharmaceutical and diagnostics giant Roche pledged on Monday to inject at least $700 million into the construction of a new plant in the United States.

Global life sciences leader to invest $700 million in Holly Springs, North Carolina, creating 400 jobs RALEIGH, N.C., May 13, 2025 /PRNewsw ...

Greentech and Roche are planning domestic manufacturing facilities, adding to the list of projects sparked by Trump's push ...

Less than a month after announcing a $50 billion investment in its U.S. operations over the next five years, Swiss pharma ...

Three players from area state championship teams are set to participate in the East-West Men's Basketball All-Star Game on July 21.

The U.S. secured over $1 billion in new manufacturing investment today on the back of President Trump’s push for more domestic production. Receive undervalued stocks, resilient to market uncertainty, ...

Kennedy Jr. said in an April 29 statement touting the administration's accomplishments. ...

Governor Josh Stein announced Monday that Genentech, one of the world’s premiere biotechnology companies, will invest $700 ...